Sensei Biotherapeutics Inc [NASDAQ: SNSE] loss -1.19% on the last trading session, reaching $0.43 price per share at the time.
If compared to the average trading volume of 331.69K shares, SNSE reached a trading volume of 8087797 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Sensei Biotherapeutics Inc [SNSE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SNSE shares is $3.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SNSE stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stephens have made an estimate for Sensei Biotherapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on May 14, 2024. The new note on the price target was released on July 01, 2021, representing the official price target for Sensei Biotherapeutics Inc stock. Previously, the target price had yet another drop from $30 to $14, while Oppenheimer kept a Perform rating on SNSE stock.
The Average True Range (ATR) for Sensei Biotherapeutics Inc is set at 0.04 The Price to Book ratio for the last quarter was 0.24, with the Price to Cash per share for the same quarter was set at 1.87.
Trading performance analysis for SNSE stock
Sensei Biotherapeutics Inc [SNSE] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.35. With this latest performance, SNSE shares dropped by -4.88% in over the last four-week period, additionally sinking by -18.72% over the last 6 months – not to mention a drop of -62.86% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SNSE stock in for the last two-week period is set at 42.89, with the RSI for the last a single of trading hit 40.58, and the three-weeks RSI is set at 44.09 for Sensei Biotherapeutics Inc [SNSE]. The present Moving Average for the last 50 days of trading for this stock 0.4695, while it was recorded at 0.4550 for the last single week of trading, and 0.5396 for the last 200 days.
Sensei Biotherapeutics Inc [SNSE]: A deeper dive into fundamental analysis
Sensei Biotherapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.84 and a Current Ratio set at 8.84.
Sensei Biotherapeutics Inc [SNSE]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SNSE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sensei Biotherapeutics Inc go to 18.72%.
An analysis of Institutional ownership at Sensei Biotherapeutics Inc [SNSE]
There are presently around $9.37%, or 14.25%% of SNSE stock, in the hands of institutional investors. The top three institutional holders of SNSE stocks are: IKARIAN CAPITAL, LLC with ownership of 0.65 million shares, which is approximately 2.5949%. VANGUARD GROUP INC, holding 0.62 million shares of the stock with an approximate value of $$0.38 million in SNSE stocks shares; and VANGUARD GROUP INC, currently with $$0.14 million in SNSE stock with ownership which is approximately 0.8934%.
